Form 4: enVVeno Medical Corp CFO Jennifer Bright Granted Stock Options
SEC Form 4
Jennifer Bright, CFO of enVVeno Medical Corp, was granted 350,000 stock options on May 19, 2025, according to a Form 4 filing.
Summary
- Jennifer Bright, the Chief Financial Officer of enVVeno Medical Corp, received 350,000 stock options on May 19, 2025.
- The options have an exercise price of $3.62.
- These options were granted under the company's Amended and Restated 2016 Omnibus Incentive Plan.
- The options vest quarterly over a three-year period, with a one-year cliff, contingent upon continued service with the company.
- The options expire on May 19, 2035.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and generally viewed as a positive incentive for management.
Positives
- The granting of stock options aligns the CFO's interests with those of the shareholders, incentivizing her to improve company performance.
Industry Context
Stock option grants are a common practice in the corporate world to incentivize executives and align their interests with those of the shareholders.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CFO.
- Employees may see this as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 2016 | Amended and Restated 2016 Omnibus Incentive Plan |
| 05/19/2025 | Date of transaction: Jennifer Bright granted stock options |
| 05/20/2025 | Date of Form 4 signature |
| 05/19/2035 | Expiration date of the stock options |
Keywords
stock options, Form 4, enVVeno Medical Corp, Jennifer Bright, CFO, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.